Coronary disease risk attributable to cardiovascular risk factors in the Spanish population;Riesgo coronario atribuible a los factores de riesgo cardiovascular en población española

Revista Espanola de Cardiologia

Volumn 60, Issue 12, 2007, Pages 1250-1256

  Medrano, María J ^a,b   Pastor Barriusob, Roberto ^b   Boix, Raquel ^b   Del Barriob, José L ^b   Damián, Javier ^b   Álvarez, Rosa ^a   Marín, Alejandro ^c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c Centro de Salud San José Norte   (Spain)

Author keywords

Cardiovascular risk factors; Coronary heart disease; Population attributable fraction; Spanish population

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CORONARY RISK; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SPAIN;

EID: 37349073856     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13113930     Document Type: Article

References (37)

1. World Health Organization. The World Health Report 2002: reducing risk, promoting healthy life. Geneve: World Health Organization; 2002.
2. Medrano MJ, Boix R, Cerrato E, Ramírez M. Incidencia y prevalencia de cardiopatía isquémica y enfermedad cerebrovascular en España: revisión sistemática de la literatura. Rev Esp Salud Pública. 2006;80:5-15.
3. Estrategia frente a la Cardiopatía Isquémica del Sistema Nacional de Salud. Madrid: Ministerio de Sanidad y Consumo; 2006.
4. Unal B, Capewell S, Critchley JA. Coronary heart disease policy models: a systematic review. BMC Public Health. 2006;6:213.
5. Rothman K, Greenland S. Modern epidemiology. Philadelphia: Lippincontt-Raven; 1998.
6. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88:15-9.
7. Nieto García FJ, Peruga Urrea A. Riesgo atribuible: sus formas, usos e interpretación. Gac Sanit. 1990;18:112-7.
8. Banegas JR, Rodríguez-Artalejo F, Graciani A, Villar F, Herruzo R. Mortality attributable to cardiovascular risk factors in Spain. Eur J Clin Nutr. 2003;57 Suppl 1:S18-21.
9. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003;57:634-8.
10. Aranceta J, Pérez C, Foz M, Mantilla T, Serra L, Moreno B, et al. Tablas de evaluación del riesgo coronario adaptadas a la población española. Estudio DORICA. Med Clin (Barc). 2004;123:686-91.
11. Medrano MJ, Boix R, Cerrato E, Delgado-Rodríguez M. Prevalencia de factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales. Med Clin (Barc). 2005;124:606-12.
12. Reina A, Colmenero M, Aguayo de Hoyos E, Aros F, Marti H, Claramonte R, et al. Gender differences in management and outcome of patients with acute myocardial infarction. Int J Cardiol. 2007;116:389-95.
13. De Velasco JA, Cosín J, López-Sendón JL, De Teresa E, De Oya M, Sellers G. Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II. Rev Esp Cardiol. 2002;55:801-9.
14. Marin A, Medrano MJ, Gonzalez J, Pintado H, Compaired V, Barcena M, et al. Risk of ischaemic heart disease and acute myocardial infarction in a Spanish population: observational prospective study in a primary-care setting. BMC Public Health. 2006;6:38.
15. Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
16. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26:S5-20.
18. Aros F, Cunat J, Loma-Osorio A, Torrado E, Bosch X, Rodriguez JJ, et al. Tratamiento del infarto agudo de miocardio en España en el año 2000. El estudio PRIAMHO II. Rev Esp Cardiol. 2003;56:1165-73.
19. Levin ML. The ocurrence of lung cancer in man. Acta Unio Internationalis Contra Cancrum. 1953;9:531-41.
20. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99:325-32.
21. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904-14.
22. Daly LE. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol. 1998;147:783-90.
23. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347-60.
24. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52.
25. Gillum RF, Mussolino ME, Madans JH. Coronary heart disease risk factors and attributable risks in African-American women and men: NHANES I epidemiologic follow-up study. Am J Public Health. 1998;88:913-7.
26. Chang M, Hahn RA, Teutsch SM, Hutwagner LC. Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992. J Clin Epidemiol. 2001;54:634-44.
27. Chambless LE, Folsom AR, Sharrett AR, Sorlie P, Couper D, Szklo M, et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol. 2003;56:880-90.
28. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005;112:3554-61.
29. Emberson JR, Whincup PH, Morris RW, Walker M. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. Eur Heart J. 2003;24:1719-26.
30. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on nutrition, physical activity, and metabolism. Circulation. 2006;113:898-918.
31. Serra Majem L, Ribas Barba L, Aranceta Bartrina J, Pérez Rodrigo C, Saavedra Santana P, Pena Quintana L. Obesidad infantil y juvenil en España. Resultados del Estudio enKid (1998-2000). Med Clin (Barc). 2003;121:725-32.
32. Brotons C, Soler-Soler J. Obesity, Cinderella of CHD risk factors. Eur Heart J. 2000;21:793-5.
33. Banegas JR, Diez Gañán L, González Enríquez J, Villar Álvarez F, Rodríguez-Artalejo F. La mortalidad atribuible al tabaquismo comienza a descender en España. Med Clin (Barc). 2005;124:769-71.
34. Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation. 2005;112:489-97.
35. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368:1651-9.
36. Eliasson M, Lindahl B, Lundberg V, Stegmayr B. Diabetes and obesity in Northern Sweden: occurrence and risk factors for stroke and myocardial infarction. Scand J Public Health. 2003;61:70-7.
37. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006;24:423-30.